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Abstract We describe a simple method for the detection
of low intensity lipid signals in complex tissue samples,
based on a combination of liquid chromatography/mass
spectrometry and ion mobility mass spectrometry. The
method relies on visual and software-assisted analysis of
overlapped mobilograms (diagrams of mass-to-charge
ratio, m/z, vs drift time, DT) and was successfully applied
in untargeted lipidomics analyses of mouse brain tissue to
detect relatively small variations in a scarce class of
phospholipids (N-acyl phosphatidylethanolamines) gener-
ated during neural tissue damage, against a background of
hundreds of lipid species. Standard analytical tools,
including Principal Component Analysis, failed to detect
such changes.
Keywords Untargeted lipidomics  Ion-mobility mass
spectrometry  Neuroinflammation  N-acyl
phosphatidylethanolamines
1 Introduction
Untargeted liquid chromatography/mass spectrometry
(LC/MS)-based analyses are widely used to profile the
lipidome of complex biological samples and to generate
testable hypotheses about the functions served by specific
lipid pathways in health and disease (Han et al. 2011;
Astarita and Piomelli 2011; Armirotti et al. 2014). By its
very nature, this type of analyses requires the acquisition of
large amounts of high-resolution MS data, typically col-
lected over a period of tens of minutes, and produces
thousands of individual data points that must be extracted
from total ion currents and compared across multiple
sample replicates. From such substantial data sets, bio-
logically relevant information may be best obtained using
unsupervised data analysis procedures such as Principal
Component Analysis (PCA) (van den Berg et al. 2006;
Ramadan et al. 2006), which has become a standard post-
acquisition tool in untargeted metabolomics (Blasco et al.
2013). Despite their proven usefulness, PCA-based untar-
geted lipidomics analyses are known to overlook rare lipid
species, which very often include molecules of consider-
able biological importance (e.g., lipids involved in cellular
signaling). As a rule, therefore, such low-abundance lipids
are investigated using targeted LC-MS/MS protocols. In
the present study, we asked whether IMS—a technique
initially developed for the detection of trace quantities of
gaseous organic compounds but recently applied with
success to metabolomics (Baker et al. 2014)—might help
to heighten the sensitivity of detection for scarce lipid
species in complex biological matrices. IMS adds an
additional gas-phase separation to LC/MS analysis (May
et al. 2015). This separation depends on the collisional
cross sections of metabolites (CCS) that closely correlate
with their chemical structure. CCS has been recently
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proposed as a tool to support metabolite identification
(Paglia et al. 2015). IMS also enables the exploration of
composite data sets using mobility-filtered ion maps—that
is, plots of m/z versus DT values, also known as mobilo-
grams—that can be subsequently interrogated using dedi-
cated search tools. Such tools allow investigators to overlap
mobilograms from different samples, selectively high-
lighting with pseudocolors of variable intensity those ions
that are differentially represented in the samples (com-
parative mobilogram analysis, CMA). To assess the use-
fulness of CMA in untargeted LC/MS-based lipidomics,
we explored the very early stages of a neuroinflammatory
process by injecting 6-hydroxy-dopamine (6-hydroxy-DA)
in the dorsal striatum of mouse brain and we performed
untargeted lipidomics analyses 48 h later, when no overt
functional alterations were yet observed. Our objective was
to probe whether CMA may help to detect small changes in
low abundance lipids that might be biologically related to
the developing pathology.
2 Materials and methods
2.1 Reagents, standards, instruments and software
Solvents and chemicals were purchased from Sigma
Aldrich (Saint Louis, MO, USA). Unless otherwise indi-
cated, all LC-MS instruments, columns and software were
from Waters Inc. (Milford, MA, USA).
2.2 Animal handling and 6-hydroxy-DA
administration
Male 8–10 weeks old mice were anesthetized with a mix-
ture of ketamine/xylazine (100 and 10 mg/kg body weight,
respectively) and placed in a stereotaxic frame with a
mouse-adaptor (Stoelting, Wood Dale, USA). 6-hydroxy-
DA was dissolved at a concentration of 3.2 lg/lL of ice-
cold 0.9 % saline solution containing 0.02 % ascorbate.
Two injections of 1 lL each were made at the following
brain atlas coordinates (in mm relative to bregma and dural
surface, Paxinos and Franklin 2001): (i) AP = ?1.0,
L = -2.1, DV = -2.9; and (ii) AP = ?0.3, L = -2.3,
DV = -2.9. Sham lesions were carried out by 1 lL
injection of 0.02 % ascorbic acid-saline at the same coor-
dinates. All procedures were performed in compliance with
Italian regulations on protection of animals used for
experimental and other scientific purposes (D.M. 116192)
as well as with European Economic Community regula-
tions (O.J. of E.C. L 358/1 12/18/1986). Forty-eight hours
after 6-hydroxy-DA injection, mice were anesthetized with
chloral hydrate (450 mg/kg) and killed by decapitation; the
brain were rapidly removed and dorsal striatum and
substantia nigra were dissected, flash frozen and stored at
-80 C.
2.3 Immunofluorescence
Mice were anesthetized with chloral hydrate (400 mg/kg),
and transcardially perfused with 20 mL of 0.9 % saline
solution followed by 60 mL of 4 % paraformaldehyde in
saline. Tissue was post fixed in paraformaldehyde 4 % for
1 h and then stored in 30 % sucrose for 3 days. Forty
micrometer sections, one every fifth, were collected and
processed for immunohistochemistry. Sections were incu-
bated with anti Iba1 (Wako, Osaka) primary antibody
followed by the secondary antibody Alexa fluor 488 (Life
science, USA). Images were collected with a Nikon A1
confocal microscopy with a 60X 1.4 numerical aperture
objective lens.
2.4 Sample preparation
Brain tissue, collected from 10 mouse brains, was trans-
ferred to pre-weighted 7 mL glass vials. Wet tissues were
then weighed and homogenized in chloroform:methanol
(1:2; vol/vol), added to each vial using a 1 mL/5 mg wet
tissue ratio. After mixing for 30 s with a Vortex, chlo-
roform (0.3 mL/5 mg tissue) and water (0.3 mL/5 mg tis-
sue) were sequentially added and mixed after each
addition. The samples were then centrifuged for 15 min at
35009g at 4 C. The organic phases (lower fractions) were
transferred to glass vials. To increase the overall recovery,
the aqueous phase (upper fraction) was re-extracted with
chloroform (0.5 mL/5 mg tissue). The two resulting
organic phases were pooled, evaporated under N2 and the
residue was dissolved in methanol/chloroform (9:1, vol/
vol; 0.1 mL/10 mg tissue). After mixing for 30 s and
centrifugation for 10 min at 50009g, 4 C), the samples
were transferred to glass vials for analyses.
2.5 Untargeted LC-IMS
Samples were loaded onto an Acquity UPLC system
coupled to a SynaptG2 QToF mass spectrometer. Lipids
were separated on a reversed-phase CSH column (2.1 9
100 mm, 1.8 lm) and eluted at 0.4 mL/min using the fol-
lowing gradient conditions: A = 10 mM ammonium for-
mate in 60:40 acetonitrile/water, B = 10 mM ammonium
formate in 90:10 isopropyl alcohol/acetonitrile; after 1 min
at 30 %, solvent B was brought to 45 % in 1 min and
maintained for 1 min, then to 50 % in 6 min, and then to
100 % in 9 min, followed by a 1 min 100 % B isocratic
step and reconditioning to 30 % B. Total run time was
21 min. Injection volume was set to 2 lL. Each sample
was acquired in triplicate. The MS instrument was operated
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in both positive and negative ion modes, setting the cap-
illary and the cone voltages at 3 kV and 35 V for ESI? and
2.2 kV and 40 V for ESI- respectively. The source tem-
perature was 90 C. Desolvation and cone gas flows (N2)
were set to 800 and 20 L/h respectively. Desolvation
temperature was set to 400 C. Ion mobility parameters
were set as follows: wave velocity and wave height were
set to 600 m/s and 40 V respectively, He cell and IMS cell
gas flows were set to 180 and 90 mL/min. respectively.
Data were acquired in both MSe and MS/MS mode (Ped-
ersen et al. 2013; Yilmaz et al. 2013) with fragmentation
performed in both the trap and the transfer regions, with the
latter method allowing parent-to-fragments realignment by
IMS (fragments are generated after the ion mobility sepa-
ration and thus they share the same drift time as their
parents). Low energy scans were acquired at fixed 4 eV
potential and high energy scans were acquired with an
energy ramp from 25 to 45 eV. Scan rate was set to 0.3 s
per spectrum. Scan range was set to 50 to 1200 m/z. Leu-
cine enkephalin (2 ng/mL) was infused as lock mass for
spectra recalibration.
2.6 NAPE synthesis
NAPEs were synthesized following the protocol described
by Guo and colleagues (Guo et al. 2010). Briefly, 0.025 g
(0.03 mmol) of 1-stearoyl-2-docosahexanoyl-sn-glycero-3-
phosphoethanolamine was dissolved in 2.5 mL chloroform
containing 0.0125 g triethylamine in a precooled 7 mL
glass vial. An appropriate acyl chloride (16:0, 17:0 or 18:0,
0.12 mmol each) in 0.9 mL chloroform was added drop-
wise. After the addition was complete, the reaction mix-
tures were heated to 40 C for 2 h and stirred overnight at
room temperature. The reactions were quenched by adding
a saturated sodium bicarbonate solution (2.5 mL), and the
organic layers were collected and washed with 3.0 mL of
0.01 M hydrochloric acid and 3.0 mL of brine. The reac-
tion mixtures were dehydrated with sodium sulfate and the
product was dried in a N2 evaporator and purified using
silica gel chromatography. The purified NAPEs were
weighed and the final amount of NAPE obtained (in mg)
was compared with the theoretical one. The reaction yield
ranged from 75 to 80 %.
2.7 Targeted NAPE analysis
The brain samples were re-extracted using the above syn-
thetic exogenous 18:0-22:6-N17:0 NAPE to a final 0.5 lM
concentration to the methanol/chloroform extraction mix-
ture. Targeted analysis of the samples was then carried out
on an Acquity UPLC system coupled with a Xevo TQ-MS
triple quadrupole mass spectrometer. NAPEs were sepa-
rated on a HSS T3 C18 column (2.1 9 50 mm, 1.7 l) at a
flow rate of 0.4 mL/min. The mobile phase consisted of
10 mM ammonium formate (pH 5) in acetonitrile/water
(60:40 v/v) as solvent A and 10 mM ammonium formate
(pH 5) in acetonitrile/ isopropyl alcohol (10:90 v/v) as
solvent B. A linear gradient program was developed for the
separation of all metabolites: 0.0–0.5 min 50 % B,
0.5–3.5 min 50 to 100 % B and 3.5–4.5 min maintained at
100 % B. The column was then reconditioned to 50 % B
for 1.0 min. The total run time for analysis was 6 min, and
the injection volume was set to 5 lL. The mass spec-
trometer was operated in the positive ESI mode and ana-
lytes were quantified using the multiple reaction
monitoring parameters indicated in Supporting Table 3.
Fig. 1 Principal Component Analysis score plots of untargeted lipidomics dataset for ESI? and ESI- modes (Panels A and B respectively). The
data reveal tissue (substantia nigra vs striatum) but no pathology-related clustering
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The capillary voltage was set at 3 kV. The cone voltage
and collision energy values were set to 25 V and 20 eV
respectively for all transitions. The source temperature was
set to 120 C. Desolvation gas and cone gas (N2) flows
were set to 800 and 20 L/h, respectively. Desolvation
temperature was set to 450 C. This method was validated
as already described (Basit et al. 2015): exogenous 18:0/
22:6/N17:0 NAPE was spiked in naive brain homogenate
and extracted (N = 3). Limit of quantification, recovery,
matrix effect, extraction efficiency were evaluated using a
calibration curve prepared with the same standard in the
0.05–50 nM concentration range.
2.8 Data analysis
Data were analyzed the using MarkerLynx software: raw
data from high-resolution LC-MS/MS runs for either
polarity (ESI? or ESI-) were subjected to a Pareto-scaled
PCA. Accurate masses (m/z) and retention time values
(RT) were included in the multivariate analysis and
Fig. 2 Mobilogram analysis of
the same dataset reported in
Fig. 1. Panels A and B: DT
versus m/z mobilograms of
lesioned (A) and control
(B) striatal tissue. Panel C
fusion map obtained by
overlapping control (yellow to
red) and lesion (blue to violet)
tissue mobilograms. A well-
defined family of signals (m/
z = 1000–1100) is highlighted
in violet (elevated in lesioned
tissue). In Panel B, the
corresponding signals are
delimited by a white polygon.
Panel D differential LC-MS
chromatogram showing 5 peaks
unequivocally elevated in
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assigned as X-variables (markers). Only markers observed
in at least 75 % of the experimental replicates were
retained. HDMS Compare software was used to overlap
ion mobility/drift time maps from different runs. Three
replicates per samples were analyzed by the software. A
visual inspection of the regions showing differentially
expressed metabolites was then performed. A region of
interest, showing clear alterations in the fusion map and
spanning from 900 to 1100 m/z and 10 to 60 ms drift time,
was further investigated by the software and differential
chromatograms and mass spectra were calculated and
reported. The corresponding m/z values were then manu-
ally extracted from the original LC-MS chromatograms for
confirmation and further inspection. Tentative but unsuc-
cessful lipid ID was carried out by interrogating the
METLIN (Smith et al. 2005; Tautenhahn et al. 2012),
HMDB (Wishart et al. 2009, 2013) and LipidMaps (Fahy
et al. 2009; Schmelzer et al. 2007) databases. Tolerance on
m/z values was set to 5 ppm. Identification was then based
on tandem mass analysis, by means of manual interpreta-
tion of the fragmentation pathways, further confirmed by
fragment ions accurate mass calculation and comparison
with reported literature on NAPEs (Astarita et al. 2008).
Further MS and MS/MS data processing and targeted
quantification of NAPEs were carried out using MassLynx
and TargetLynx softwares. Statistical analysis of NAPE
upregulation was performed using GraphPad Prism 5
(GraphPad Software, La Jolla, CA, USA). Data were ana-
lyzed using the Student’s t test, comparing control and
lesioned groups. A P value \0.05 was considered
significant.
3 Results and discussion
We injected 6-hydroxy-DA, a toxic compound that selec-
tively destroys dopaminergic axon terminals (Morales et al.
2015, Le et al. 2014), into the striatum of mice and, 48 h
later, sacrificed the animals, snap-froze their brains, and
collected two target regions—striatum and substantia
nigra—for lipid analysis. The substantia nigra was included
because it contains the cell bodies of the striatal
dopaminergic terminals damaged by 6-hydroxy-DOPA
(Blesa and Przedborski 2014). Samples of striatum and SN
taken from the left (control) and right (lesioned) hemi-
spheres from 10 mouse brains were collected separately,
Fig. 3 Panel A The extracted ion currents of the 5 signals described
in Fig. 2 magnified 100 folds to become visible when compared to the
corresponding 50–1200 m/z total ion current (upper trace). Panel B
representative mass spectrum of molecule 5 (1042.82 m/z, ESI?). The
corresponding peak is magnified tenfolds. Panel C overlapped
extracted ion traces of fragment ion m/z = 310.31 from control
(black trace) and lesioned hemisphere (red trace). Panel D
overlapped extracted ion traces of fragments m/z = 310.31 (red)
and a fragment ion of sphingoid base (m/z = 246.26 d18:1; black
trace)
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producing a total of 4 experimental groups. Following
untargeted high-resolution LC-MS/MS, the data were
analyzed using PCA. The score plot reported in Fig. 1
suggests the existence of regional differences in lipid
composition between striatum and SN, but does not reveal
any statistically detectable change related to 6-hydroxy-
DOPA treatment. Nevertheless, immunohistochemical
experiments revealed the presence of detectable neural
damage in the striatum (as assessed by measuring micro-
glia cell activation, see Supplementary Fig. 1). Because
injury and inflammation have been associated with alter-
ations in multiple low-abundance lipid species in the brain
(Esposito et al. 2014; Hansen et al. 2000), this negative
finding highlights the difficulty in detecting such species
Fig. 4 Fatty acyl chain
composition of the observed
NAPEs
Fig. 5 Tandem mass spectra analyses of brain-derived NAPE (18:0/22:6/N18:0) under ESI? (Panel A) and ESI- (Panel B) conditions
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using standard PCA-based lipidomics protocols. The same
set of samples was then re-acquired in the IMS mode and
dedicated software (HDMS Compare) was used to com-
pare the profiles of lesioned and unlesioned striatal tissue.
The HDMS Compare software was originally designed to
support the characterization of complex organic materi-
als—including mineral oils, fuels, polymers and biophar-
maceuticals. Mobilograms (DT vs m/z diagrams) were then
calculated for each run and compared for the two experi-
mental conditions. Several differently regulated signals,
whose nature is still under investigation, were detected.
Among them, a sharp and well-defined group of signals of
large molecular weight (m/z = 1000–1100) showing a
marked upregulation in lesioned striatum was selected for
further investigation. The results are reported in Fig. 2.
Panels A and B show enlarged mobilograms of the lesioned
and control tissues, respectively. The mobilograms were
combined to generate the Fusion Map reported in Fig. 2
panel C. This panel reports differentially regulated signals
using blue to violet colors for the lesioned tissue and yel-
low to red colors for the control tissue. These signals
(circled by the white line in Fig. 2 panel A) were clearly
noticeable due to their marked upregulation (deep blue to
violet in the Fusion Map). A complete Fusion Map show-
ing the full m/z and RT range is reported in Supplementary
Fig. 2 where the black square indicates the investigated
signals. On the basis of these ion mobility data, we were
able to extract from the total ion current 5 peaks (Fig. 2,
panel D) and 5 corresponding m/z values (Fig. 2, panel E)
that were clearly increased in lesioned tissues relative to
controls (named 1–5, details reported in Table 1). Notably,
as reported in Fig. 3, panel A, these signals needed to be
magnified to become visible from the corresponding total
ion current in the 50–1200 m/z range. As an example, the
mass spectrum of peak 5 (m/z = 1042.82) is reported in
Fig. 3, panel B (109 magnification). The signals were
detected as [M?H]? and [M?NH4]
? adducts in the posi-
tive ion mode, or as [M-H]- adducts in the negative ion
mode. One of their key features was an ESI? fragment ion
with m/z = 310.31 (C20H40NO, 0.6 ppm mass accuracy).
The corresponding ion trace (Fig. 3, panel C) when
extracted from the high-energy chromatograms acquired in
MSe mode from the control (black trace) and lesioned (red
trace) hemispheres, provides an estimate of the relative
increase experienced by these lipid species following
6-hydroxy-DA injection. Moreover, in order to obtain a
rough indication of the relative abundance of these lipids,
and taking into consideration all the differences in struc-
ture, ionization and fragmentation, we overlapped the ion
current of fragment m/z = 310.31 to a well-known frag-
ment ion that is diagnostic of ceramides and glycosylce-
ramides (m/z 264.26; double water loss on d18:1 sphingoid
base). The corresponding plot (Fig. 3, panel D) gives an
indication of the relative abundance of these lipids (red
trace) relative to the d18:1 sphingolipid content (black
trace). For each of these unknown molecules we calculated
the best guess for the molecular formula, on the basis of the
accurate mass and isotopic profile. All data are reported in
Supporting Table 1. The maximum intensities of these
signals ranged between 1 and 3 % of the total ion current
measured at the same retention times, explaining why they
were not detected by standard PCA analysis or visual
inspection of the chromatograms. Surprisingly, neither the
accurate masses nor the guessed molecular formulas, when
searched against the LIPIDMAPS, METLIN and HMDB
databases, returned any hit compatible with the observed
isotopic profile, the chromatographic retention time or the
adduct type that are normally observed in untargeted lipi-
domics analysis using our LC-MS/MS setup (Cajka and
Fiehn 2014). More importantly, none of the proposed hits
was consistent with the high-resolution tandem mass
spectra of these lipids. A closer analysis of such data
allowed us to tentatively identify the molecules as a sub-
family of NAPEs (see Fig. 4 and Supporting Table 2)
bearing a polyunsaturated chain (either 22:6 or 20:4) at the
sn-2 position of the glycerol moiety, and a saturated chain
(16:0 or 18:0) at the N-acyl position. The latter moiety
generates upon fragmentation the m/z = 310.31 ion men-
tioned above. As an example, a detailed interpretation of
the ESI? and ESI- MS/MS spectra of lipid 3 (NAPE 18:0-
22:6-N18:0, 1058.8170 m/z in ESI?) is provided in Fig. 5.
Close inspection of the data allowed us to discriminate
fragment ion m/z = 283.26, which originates from the 18:0
fatty acyl chain from the fragment m/z = 283.24 generated
by CO2 loss from 22:6 fatty acyl chain in sn-2 (Song et al.
2007). For two of these signals (m/z = 1030.70 and
1014.78), MS/MS analysis revealed the presence of two
coeluting isomeric lipids, both carrying 22:6 at sn-2 and a
reciprocally mass-compensating combination of 18:0 or
16:0 at sn-1 and N-acyl (for m/z = 1030.70) or P-16:0/P-
18:0 as sn-1 reciprocally compensating 18:0 or 16:0 as
N-acyl (for m/z = 1014.78). Together, the data identify a
group of seven lipids generating five signals detected by
IMS analysis. To confirm the compound identification, we
synthesized two of these molecules (18:0/22:6/N16:0 and
18:0/22:6/N18:0) and subjected them to LC/MS analysis
(Guo et al. 2010; Astarita et al. 2008). The standards
showed identical chromatographic and MS/MS behavior as
tissue-derived analytes (Supporting Information 1). We
also tested the possibility to discriminate the two sn-2 fatty
acyl chains (20:4 and 22:6) by using IMS. This was done
by performing the MS/MS in the trap region and then
allowing the fragments to drift in the mobility section of
the instrument. The results are reported in the Supple-
mentary Figure 3. The glycerol fragments deriving from
the loss of the phosphate group, thus still bearing the sn-1
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and sn-2 acyl chains, were subjected to gas phase drift in
the IMS region. Fragments bearing 22:6 as sn-2 (from
(18:0/22:6/N18:0)) showed a DT value exactly overlapping
that of the authentic synthetic standard (Panels A and B)
and were clearly distinguishable from the fragment bearing
20:4 (from (18:0/20:4/N18:0), Panel C). According to these
data, chain 20:4 is less ‘‘bulky’’ than 22:6 in the gas phase
and thus the corresponding fragment ion needs roughly 0.4
milliseconds less to exit the drift region with this setup. We
then further explored the overall potential of our IMS
protocol by testing it for absolute sensitivity, linearity and
selectivity toward NAPEs. The results are reported in the
Supporting Data document available for download. Using
the synthetic NAPEs as benchmark and the chromato-
graphic setup used for targeted analysis (see the Method
section), we compared the absolute sensitivity in MS, IMS
and MRM (Multiple Reaction Monitoring) acquisition
modes. Although the triple-quad MRM sensitivity excee-
ded both scan acquisition modes, as expected, IMS enabled
a significantly higher sensitivity than MS, with a much
higher S/N ratio for a 5 nM calibrator of both synthetic
standards (Supplementary Data, Figures 1 and 2). We then
compared the instrumental response linearity over more
than 3 concentration logs (1–5000 nM): IMS performed
significantly better than did MS (Supplementary Data,
Figure 3). Finally, we mimicked an untargeted metabo-
lomic experiment by spiking exogenous 18:0/22:6/N17:0
NAPE in brain homogenate at concentrations ranging from
10 ppb to 10 ppm and we acquired the samples in IMS
mode. The CMA allowed us to detect the exogenous lipid
down to a 1 ppm level (Supplementary Data, Figure 4). At
this concentration, PCA analysis and chromatogram over-
lapping failed to detect the presence of the exogenous lipid
in the matrix (Supplementary Data, Figures 5 and 6).
Finally, in order to obtain a reliable quantification of these
lipids in the brain, we developed a dedicated targeted
method using the triple-quadrupole instrument. Lipids were
quantified using a calibration curve prepared with synthetic
standards, and authentic odd-chain NAPE (18:0-22:6-
N17:0) as internal standard. A full validation of this MRM
method was also performed, by testing it for linearity, limit
of quantification, recovery, matrix effect and extraction
Fig. 6 NAPE levels in control (empty bar) and lesioned (red bar) mouse striatum. ***P\ 0.01, 2 tailed t test, N = 10 per group
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efficiency from brain as previously described (Basit et al.
2015). The corresponding results are reported in the Sup-
porting Table 4. After a new tissue extraction, the levels of
the seven NAPE species observed were then quantified.
The results, shown in Fig. 6, are in good agreement with
those previously reported in the literature (Astarita et al.
2008). We conclude that 6-hydroxy-DA lesions elevated
NAPE levels in striatal tissue from approximately
10–250 pmol/g to 200–1000 pmol/g. No such change was
observed in the SN of the same hemisphere, confirming the
highly localized nature of the response.
4 Conclusions
The present study shows that signals representing only a
small fraction (1–2 %) of the total ion current measured at
a given retention time, but that are markedly different
between two experimental conditions, can be readily
detected by mobilogram comparison even though they are
likely to go unnoticed in standard analyses. The reason for
this enhanced selectivity lies in the added gas-phase sep-
aration that allows for a significantly higher S/N ratio than
standard MS. This, together with the highly reproducible
LC retention time ensured by UPLC, greatly increases the
efficiency in differences detection in metabolomics com-
parisons. We confirmed the usefulness of this approach by
detecting changes in the levels of a scarce class of phos-
pholipids, the NAPEs, in the highly complex lipidome of
the brain, where PCA had failed. Although the biological
functions of the NAPEs are still poorly understood
(Wellner et al. 2013), their biosynthesis is known to be
stimulated by tissue damage (Janfelt et al. 2012; Hansen
et al. 2000). Thus, when challenged with a complex bio-
logical sample, the new method was able successfully to
detect elevations in individual lipid species naturally pre-
sent in the brain at low ppm to ppb levels. This higher level
of selectivity can be of great value in neural lipidomics,
given the 4–5 log concentration span of the lipid species
normally present in brain tissue.
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